Objective: Aiming at the determination of the vaccination rate against HBV among dentists and at the evaluation of the antibody seroprevalence in the same population in a serological screening performed among dentists from Goiania, Central West region of Brazil, a randomized sample of 678 professionals among 3,030 registered in the Regional Council of Dentistry were included in this study. Methods: Each participant answered a questionnaire about HBV vaccination and risk factors for HBV infection after a written consent and a blood sample was collected from each dentist for the determination of the serological markers: HBsAg, anti-HBsAg and total anti-HB by an immunoenzymatic method using comercial kits (Bioelisa -
Results: Positives results for total anti-HBc were observed in 38 dentists (5.6%) and none of than were positive for the HBsAg. A high vaccination rate of 98.4% was observed, although 11.4% of the individuals did not complete the three dose vaccination schedule. This is a cross sectional study on the seroprevalence of the serological markers and, therefore, it does not allow for vaccine response analysis, considering the need for pre- and post-exposure evaluation in such cases. From 629 vaccinated dentists that were negative for total anti-HBc, 86.3% had an anti-HBsAg positive result.
Conclusions: A high prevalence of vaccinated dentists and high rate of immunity conferred by the vaccine were observed, which may represent a positive impact of the national vaccination program for risk groups in